|
Mutation Information
|
Mutation Site
|
T215F |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Genotype/Subtype
|
B |
|
Country
|
Canada;US |
Literature Information
|
PubMed PMID
|
18666824
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2008 |
|
Journal
|
PLoS medicine |
|
Title
|
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy. |
|
Author
|
Johnson JA,Li JF,Wei X,Lipscomb J,Irlbeck D,Craig C,Smith A,Bennett DE,Monsour M,Sandstrom P,Lanier ER,Heneine W |
|
Evidence
|
The remaining resistance mutation assays identified eight (4%) K103N, seven (3.5%) L90M, three (1.5%) Y181C, two (1.5%) M184V, one (0.5%) T215Y, and four (2%) T215F samples. Four samples (2% overall) had the following mutations to two drug classes: L90M+M184V, L90M+Y181C, Y181C+T215F, and L90M+M41L+K70R.
|
|
|
HIV Mutation Detail Information